Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Bradford | OTHER |
Not provided
Not provided
Not provided
Not provided
Point of care testing (POCT) is described as a laboratory test conducted near the patient with a rapid result obtained through a portable analysing device, as opposed to the collection of a blood sample being transferred to a central laboratory for analysis and reporting.
Over the past 15 years increasing emphasis has been placed upon the paramedic profession as a possible solution to addressing the increasing demands placed on emergency departments. This is largely viewed through the ability of paramedics to assess patients calling 999 and manage a patient's condition away from the emergency department, with sufficient evidence supporting the role of the paramedic to develop competencies to manage larger volumes of patients.
This feasibility study will seek to understand whether paramedics report that the use of POCT devices is useful in safe clinical decision making with patients in the community, and if it is possible to use the Abbott i-STAT device in the urgent and emergency care setting for those patients where management within the community is being considered.
Given that there is very little evidence in this subject area, the research should start to inform the potential for future innovations in paramedic and community practice, and build on the body of evidence regarding POCT by paramedics related to community management.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Abbott i-stat Allinity | Experimental | Randomised patients to this arm receive the application of the point of care testing device to provide further diagnostic information to assist clinical decision making. |
|
| Usual Care | Placebo Comparator | Randomised patients to this arm receive usual care. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Interventional Diagnostic Device Arm | Device | Point of care testing venous blood diagnostic device. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Self-reported impact of using POCT device | Qualitative focus group data measuring perceived self-reported impact by advanced practitioner (paramedic). | 1.5 hours focus group at end of study |
| Measure | Description | Time Frame |
|---|---|---|
| Non-conveyance rate | Proportion of cases not conveyed to hospital | Through study completion, expected to be 6 months |
| 72 hour re-contact rate | Proportion of non-conveyed hospital where there was a re-contact to the ambulance service |
Not provided
Inclusion Criteria:
- Paramedic Participants
Inclusion criteria:
Patient Participants
Inclusion criteria:
Exclusion Criteria:
-
Paramedic Participants:
• Any HCPC registered advanced practitioner (paramedic) who is currently under investigation for fitness to practice.
Patient Participants
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Andrew Hodge | Contact | +447798640414 | andrew.hodge1@nhs.net | |
| Bryan Lightowler | Contact | b.lightowler@bradford.ac.uk |
| Name | Affiliation | Role |
|---|---|---|
| Andrew Hodge | Yorkshire Ambulance Service | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D004630 | Emergencies |
| ID | Term |
|---|---|
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Single site feasibility study
Not provided
Not provided
Patient is randomised to control or intervention arm after consent obtained.
| Usual care | Other | Usual care provided to patient without use of point of care testing device |
|
| Through study completion, expected to be 6 months |
| Type of POCT cartridges used. | Type of POCT cartridges used. | During the procedure |
| Number of POCT cartridges used. | Number of POCT cartridges used. | During the procedure |
| Number of successful and unsuccessful attempts in using the POCT device. | Number of successful and unsuccessful attempts in using the POCT device recorded as a measurement of failure rates | During the procedure |
| Length of time on scene. | Understanding any changes to time spent with patient | immediately after the patient care episode has ended |
| Number of patients who receive POCT. | Descriptive data to understand how many patients were eligible for the POCT device | Through study completion, expected to be 6 months |
| Patient demographics and presentations where POCT is applied - age, gender, NEWS2 score, clinical condition. | Descriptive data to understand patient characteristics of those patients enrolled into study | Through study completion, expected to be 6 months |
| Feasibility of patient randomisation process | Descriptive data to record number of successful and unsuccessful attempts at randomisation of eligible patients | Through study completion, expected to be 6 months |